APD
52
-2
AFL
41
-4
AN
30
-2
AAP
30
7
VIX
52
5
AVB
14
-8
ES
84
2
ETN
64
3
AMP
31
-6
AA
67
-3
CF
38
2
AMZN
40
2
AES
73
7
DVN
54
4
ED
59
7
AMGN
59
4
BLK
49
-6
CRM
22
-3
CAG
41
7
EA
38
-14
APD
52
-2
AFL
41
-4
AN
30
-2
AAP
30
7
VIX
52
5
AVB
14
-8
ES
84
2
ETN
64
3
AMP
31
-6
AA
67
-3
CF
38
2
AMZN
40
2
AES
73
7
DVN
54
4
ED
59
7
AMGN
59
4
BLK
49
-6
CRM
22
-3
CAG
41
7
EA
38
-14
Financhill
Back

Starpharma Holdings Ltd. 10K Form

Buy
53

SPHRY
Starpharma Holdings Ltd.

Last Price:
$3.15
Seasonality Move:
8.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SPHRY News And Ratings

See the #1 stock for the next 7 days that we like better than SPHRY

SPHRY Financial Statistics

Sales & Book Value

Annual Sales: $3.2M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.34
Price / Book: 1.9

Profitability

EPS (TTM): -0.04830
Net Income (TTM): $-2M
Gross Margin: $1.7M
Return on Equity: -43.48%
Return on Assets: -33.77%

Starpharma Holdings Ltd. Earnings Forecast

Key Starpharma Holdings Ltd. Financial Ratios

  • The Gross Profit Margin over the past 24 years for SPHRY is 53.30%.
  • The Selling, General & Administrative Expenses for SPHRY have been equal to 127.46% of Gross Profit Margin.
  • The Research & Development expenses have been 340.18% of Revenue.
  • The Net Earning history of SPHRY is -203.38% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 12 years.

Starpharma Holdings Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SPHRY
Website: starpharma.com

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 5.41
Quick Ratio: 4.93

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SPHRY Technical Analysis vs Fundamental Analysis

Buy
53
Starpharma Holdings Ltd. (SPHRY) is a Buy

Is Starpharma Holdings Ltd. a Buy or a Sell?